{"id":"https://openalex.org/W2021930898","doi":"https://doi.org/10.1016/j.lfs.2005.09.018","title":"The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine","display_name":"The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine","publication_year":2005,"publication_date":"2005-11-10","ids":{"openalex":"https://openalex.org/W2021930898","doi":"https://doi.org/10.1016/j.lfs.2005.09.018","mag":"2021930898","pmid":"https://pubmed.ncbi.nlm.nih.gov/16288927"},"language":"en","primary_location":{"id":"doi:10.1016/j.lfs.2005.09.018","doi":"https://doi.org/10.1016/j.lfs.2005.09.018","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.lfs.2005.09.018","pdf_url":null,"source":{"id":"https://openalex.org/S175775512","display_name":"Life Sciences","issn_l":"0024-3205","issn":["0024-3205","1879-0631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Life Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029621910","display_name":"Robert N. Pechnick","orcid":"https://orcid.org/0000-0002-2238-9964","observed_orcids":["https://orcid.org/0000-0002-2238-9964"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert N. Pechnick","raw_affiliation_strings":["Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA. pechnickr@cshs.org","Brain Research Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA","Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA. pechnickr@cshs.org","institution_ids":["https://openalex.org/I1282927834"]},{"raw_affiliation_string":"Brain Research Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013195713","display_name":"Catherine J. Bresee","orcid":"https://orcid.org/0000-0002-5710-4906","observed_orcids":["https://orcid.org/0000-0002-5710-4906"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine J. Bresee","raw_affiliation_strings":["Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049632289","display_name":"Russell E. Poland","orcid":"https://orcid.org/0000-0003-4395-5811","observed_orcids":["https://orcid.org/0000-0003-4395-5811"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell E. Poland","raw_affiliation_strings":["Brain Research Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA","Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain Research Institute, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Department of Psychiatry and Mental Health, Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA, 90048, USA","institution_ids":["https://openalex.org/I1282927834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029621910"],"corresponding_institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"],"apc_list":{"value":3810,"currency":"USD","value_usd":3810},"apc_paid":null,"fwci":0.3963,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.52923538,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"78","issue":"17","first_page":"2006","last_page":"2011"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.6898999810218811,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.1388999968767166,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.08940000087022781,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nmda-receptor-antagonism","display_name":"NMDA receptor antagonism","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dopamine-reuptake-inhibition","display_name":"dopamine uptake inhibition","score":0.9750000238418579},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis","display_name":"hypothalamic-pituitary-adrenal axis","score":0.8999999761581421},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.8379999995231628},{"id":"https://openalex.org/keywords/acth","display_name":"ACTH","score":0.9309999942779541},{"id":"https://openalex.org/keywords/corticosterone","display_name":"corticosterone","score":0.996999979019165},{"id":"https://openalex.org/keywords/transmission-control-protocol","display_name":"TCP","score":0.5370000004768372},{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/monoamine-reuptake-inhibitors","display_name":"monoamine reuptake inhibitors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/neuroendocrine-effects","display_name":"neuroendocrine effects","score":0.8980000019073486}],"concepts":[{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.839767336845398},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.7783381938934326},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6702629327774048},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5964996814727783},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.542932391166687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5305833220481873},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5297202467918396},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.4677807092666626},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.41348734498023987},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.31381064653396606},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25885552167892456},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1564144790172577},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06402567028999329}],"mesh":[{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003345","descriptor_name":"Corticosterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.lfs.2005.09.018","doi":"https://doi.org/10.1016/j.lfs.2005.09.018","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.lfs.2005.09.018","pdf_url":null,"source":{"id":"https://openalex.org/S175775512","display_name":"Life Sciences","issn_l":"0024-3205","issn":["0024-3205","1879-0631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Life Sciences","raw_type":"journal-article"},{"id":"pmid:16288927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16288927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Life sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3568817264","display_name":"NEUROENDOCRINE EFFECTS OF PHENCYCLIDINE","funder_award_id":"R01DA004113","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1824863696","https://openalex.org/W1940282268","https://openalex.org/W1953634463","https://openalex.org/W1967181685","https://openalex.org/W1969514496","https://openalex.org/W1974164981","https://openalex.org/W1978989737","https://openalex.org/W1986477161","https://openalex.org/W1988870167","https://openalex.org/W1989314580","https://openalex.org/W1992850680","https://openalex.org/W1995248567","https://openalex.org/W2018407797","https://openalex.org/W2026566819","https://openalex.org/W2032251095","https://openalex.org/W2036395950","https://openalex.org/W2045896071","https://openalex.org/W2050106701","https://openalex.org/W2052104518","https://openalex.org/W2076254970","https://openalex.org/W2079048674","https://openalex.org/W2079764039","https://openalex.org/W2093052238","https://openalex.org/W2119166491","https://openalex.org/W2151040629","https://openalex.org/W2168108617","https://openalex.org/W2168109086","https://openalex.org/W2230226274","https://openalex.org/W2259330911","https://openalex.org/W2274397843","https://openalex.org/W4300748935","https://openalex.org/W6640436057","https://openalex.org/W6689202039"],"related_works":["https://openalex.org/W1988870167","https://openalex.org/W2005976531","https://openalex.org/W2273297753","https://openalex.org/W1970862669","https://openalex.org/W2036395950","https://openalex.org/W2072808729","https://openalex.org/W2259330911","https://openalex.org/W2058450062","https://openalex.org/W2024727718","https://openalex.org/W1978159715"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}